IVY RX Review: What the $77 GLP-1 Starting Price Does—and Does Not—Tell You

The most important number in IVY RX’s weight-loss offer is not necessarily the largest one on the page. The provider advertises GLP-1 medication “From $77” and microdose GLP-1 “From $69,” each alongside “4 doses/month.” Those figures identify entry-level offers, but the consulted material does not connect either price to a specific molecule, prepaid option or complete checkout total. For someone comparing out-of-pocket costs, the central question is what will actually be charged now—and what authorizes the next charge.

IVY RX documents a real telemedicine offering: online health questions, clinician review, potential prescribing through a partner pharmacy, delivery and portal messaging. Its commercial pages also advertise a free consultation and no insurance requirement. This documentary review examines those services through their payment implications, using sources consulted October 19, 2026. The result is a mixed picture: several useful inclusions are stated, but the relationship between headline prices, subscription options, future fees and refunds needs written clarification before purchase.

At a glance

Advertised GLP-1 entry price: From $77, displayed with “4 doses/month”; the material does not establish a universal price for both semaglutide and tirzepatide.
Sources: [7]
Microdose entry price: From $69, also displayed with “4 doses/month,” for an offering described as compounded semaglutide or tirzepatide.
Sources: [5]
Payment structure: Terms describe either one month prepaid or three months prepaid, followed by month-to-month automatic renewal; neither option is mapped to the advertised starting prices.
Sources: [9]
Advertised inclusions: The site advertises a free consultation and free delivery; GLP-1 pages also describe portal messaging, live support and a free mobile app.
Sources: [8] [7]
Refund boundary: Terms permit a refund request within 15 days of the order, without guaranteeing approval. The separate returns policy does not accept physical returns.
Sources: [9] [12]

Start with the charge, not the headline

IVY RX’s standard GLP-1 page identifies compounded tirzepatide and semaglutide, then advertises medication from $77 with four doses per month. Its microdose page uses a similar presentation, starting at $69. Neither excerpt establishes which molecule, formulation details or purchase conditions unlocks the lowest amount. The sensible reading is therefore a starting offer, not a confirmed monthly quote for either drug. The catalog separately lists GLP-1 injections, microdose products and oral melts; those menu entries should not be treated as interchangeable purchases.

The wording also leaves the relationship between medication quantity and billing unresolved. “4 doses/month” is the provider’s commercial description, not proof of a four-week billing cycle, a particular vial quantity or a complete supply specification. The subscription terms use months, while the product pages emphasize doses. Our explanation of how the first payment can differ from the advertised price provides a useful framework: obtain the exact product, amount collected today and next scheduled charge together, rather than interpreting any one number alone.

A written quote should identify whether the $77 or $69 offer applies to the proposed prescription, which prepaid option is selected and whether anything else is charged separately. The supplied evidence does not establish injection-supply inclusions, applicable coupons or prepaid discounts. These are unresolved details, not evidence that additional charges necessarily exist. Equally, there is no basis here to invent a higher total or assume that the lowest advertised figure covers every available presentation.

The advertised amounts and the remaining payment questions
Offer or term	What is documented	What still needs confirmation
GLP-1 medication	From $77; 4 doses/month	Qualifying molecule, presentation and checkout total
Microdose GLP-1	From $69; 4 doses/month	Qualifying product and applicable payment option
One-month option	One month prepaid; monthly autorenewal	Initial amount and next charge date
Three-month option	Three months prepaid; monthly autorenewal	Upfront amount and renewal transition
GLP-1 Boost supplement	From $72 for 30 tablets	Final price and clarification of presentation inconsistencies

Sources: [7] [5] [6] [9]

Prepayment and renewal change the budget

The billing terms describe a self-pay arrangement and authorize automatic subscription renewal with charges to the customer’s credit card. They offer two structures: one month prepaid with month-to-month autorenewal, or three months prepaid with month-to-month autorenewal. This is a choice between stated structures, not evidence that every customer must prepay three months. The documents do not assign the $77 and $69 offers to either structure or explain the precise transition from a three-month prepaid period to monthly charges.

That distinction matters because a monthly-looking advertisement does not establish the amount collected at enrollment. Nor does the existence of a three-month option establish a medication quantity, discount or universal minimum commitment. Readers can use our guide to monthly, four-week and prepaid billing to organize the questions. For IVY RX specifically, ask for the initial debit, the period it covers, the renewal date and the renewal amount in the same written response.

There is also a meaningful tension between marketing and contract language. The GLP-1 page says “Same price, every dose,” but the terms reserve the right to increase subscription fees at IVY RX’s discretion. That marketing statement therefore should not be read as an indefinite price guarantee. The evidence does not supply a distinct introductory-versus-renewal price schedule. A buyer needs confirmation of the current recurring fee and how any future change would be communicated, rather than an assumption that today’s offer is permanently locked.

Sources: [9] [7]

What the advertised price appears to include

The homepage advertises a free consultation, no insurance requirement and free, discreet delivery. The GLP-1 page adds temperature-controlled packaging, live support and a free mobile app. Those are useful stated benefits, particularly when comparing programs that separate access fees from medication charges. Nevertheless, the consultation excerpt does not define its scope or exclusions, and the evidence does not provide a complete itemized service agreement showing every component included in each starting-price offer.

IVY RX says patients can securely message their care providers through its portal. That establishes a contact route, but not a documented follow-up schedule, guaranteed response time or unlimited clinical service. The consulted material also does not settle prescription-renewal requirements or whether every possible follow-up interaction is included. Our guide to what a GLP-1 program price includes is relevant here: medication access, scheduled clinical review and administrative support are distinct services even when sold under one subscription.

On payment funding, the site says insurance is not needed, while the terms explicitly describe self-pay. IVY RX also claims GLP-1 therapy is HSA/FSA-eligible and says it supplies an itemized receipt for reimbursement submissions. That is the provider’s statement, not a guarantee that a particular account administrator will approve a claim. Confirm the documentation required by the relevant plan before treating potential reimbursement as money already available to offset the subscription.

Sources: [8] [7] [9]

What happens between enrollment and a prescription

The documented intake begins with an online questionnaire about symptoms and health history. For prescription products, IVY RX says it arranges a consultation with a qualified healthcare provider; if approved, a partner pharmacy can fill the prescription. The GLP-1 page advertises same-day physician review and emailed approval, but this is not a promise that every applicant receives medication. The site also says laboratory work is not needed for access. That describes its advertised process, not an independent judgment about any individual’s evaluation needs.

IVY RX states that its affiliated doctors are board-certified, U.S.-licensed healthcare professionals. Those credentials were not independently verified in this review, and the supplied material does not name the clinician who would assess a particular applicant. Likewise, the evidence does not establish available states or territories, video-consultation availability or Spanish-language services. Confirm geographic eligibility before paying; a Miami contact address is not proof of nationwide prescribing coverage or an in-person care location.

Eligibility messaging requires extra care. Terms limit site and app use to adults aged 18 or the applicable age of majority. Separately, the BMI calculator marks below 22 as ineligible, labels microdose below 24.99 and full-dose above 25. These labels overlap or leave boundary values unclear; they are not a reliable stand-alone eligibility rule. NIDDK describes general adult pharmacotherapy thresholds of BMI 30, or 27 with weight-related health problems, while emphasizing individualized clinical evaluation. Ask IVY RX to explain its criteria rather than resolving the calculator yourself. The provider’s published safety block also lists personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2 (MEN2) as contraindications, and says not to take the described medication during pregnancy, while trying to become pregnant or while breastfeeding. However, the injections page labels this block “Microdose GLP-1”; confirm with the clinician which product-specific restrictions apply.

Sources: [8] [7] [5] [9] [2]

Pharmacy claims and delivery expectations

IVY RX says its preparations are compounded in pharmacies compliant with 503B/USP <797> standards. It also describes state-licensed pharmacy preparation and independent verification in FDA- and DEA-registered laboratories. The material does not name those pharmacies or laboratories, so these remain attributed provider claims rather than independently established findings. Its advertised quality checks include potency testing every three to six months within ±10% of target strength and sterility screening for bacteria, fungi and other contaminants.

These statements do not establish FDA approval of the preparations. FDA explains that compounded drugs are not FDA approved and do not receive its premarket review for safety, effectiveness and quality; nonapproval alone does not demonstrate clinical inequivalence. FDA recommends compounded medicines when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. The useful purchasing question is which pharmacy will prepare or dispense the specific prescription and what documentation accompanies it—not whether laboratory registration makes the product approved.

Delivery language also needs separating. A product page advertises receipt “in as little as 2 days,” while the help center says delivery usually takes three to five business days. Both are arrival claims, distinct from same-day clinical review; neither establishes a universal delivery guarantee. IVY RX advertises free temperature-controlled packaging, but the consulted evidence does not explain replacement procedures for temperature problems. FDA explicitly advises not using injectable GLP-1 medication that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy.

Sources: [7] [11] [1]

Cancellation stops future charges; refunds are separate

The weight-loss page says there are no long-term contracts or cancellation fees. The terms nevertheless describe prepaid subscription periods and require cancellation before the current period ends to avoid the subsequent monthly charge. One billing clause permits cancellation or plan modification through the patient portal; another section directs customers to support. These statements should be read together: an advertised absence of cancellation fees does not mean that prepaid money is automatically refundable or that a renewal already charged will be reversed.

The separate returns policy says physical returns are not accepted and invites customers to contact the company about problems. Meanwhile, the terms permit dissatisfied customers to request a refund within 15 days of the order. Requests must go to info@ivyrx.com with the subject “Refund Request”; after that period, the terms describe sales as final and ineligible for refunds. The right to submit a request is not a promise of approval, and the material does not clarify how this applies to prescribed or already-shipped products.

Before enrolling, ask which cancellation route controls, when cancellation becomes effective and how confirmation is provided. Keep that response with the payment authorization and any refund correspondence. Our guide to cancellation versus getting money back explains the distinction, but IVY RX’s own written answer remains essential for its prepaid options. The available documents do not establish a guaranteed refund-processing period or a bank-arrival deadline, so neither should be assumed when planning a budget.

Sources: [9] [6] [12]

Keep supplements and other catalog products out of the comparison

IVY RX’s broader catalog can complicate a price comparison if similarly named products are grouped together. GLP-1 Boost is advertised as a supplement from $72 for 30 tablets, not as prescription GLP-1 medication. Its FAQ expressly says it contains no GLP-1 or synthetic peptides. The product’s safety information acknowledges limited robust human clinical data for the exact combination and says it is not a substitute for prescribed medication. Its price therefore should not be used as another prescription-program quote.

The Boost material also contains presentation inconsistencies: the offer says tablets, composition information describes a vegetable capsule and a testing block refers to an injection. Those mismatches warrant clarification about the actual product being purchased; they do not establish what a shipped package contains. Separately, the main catalog lists Ozempic, Mounjaro, metformin, MIC + B12 injections and anti-nausea tablets. A navigation listing alone does not confirm current availability, prescribing conditions or inclusion in either advertised GLP-1 starting price.

Sources: [6] [10]

Get an accountable answer before authorizing payment

IVY RX publishes several contact paths with different apparent purposes. The general contact information lists 866-464-8979 and hello@ivyrx.com, plus 111 NE 1st Street, 8th Floor #8564, Miami, FL 33132. The returns policy lists support@ivyrx.com and says support is available seven days a week, without specifying hours or response times. Refund requests have the separate terms-based email procedure described above. Use the channel suited to the issue, and retain a copy rather than assuming every inbox follows the same process.

There is also an unresolved business-identity detail: the terms name Ivy Rx, PLLC as the contracting party, while the supplied evidence notes an Ivy Health Inc. footer. Their relationship is not clarified here. Before authorizing recurring charges, request a written summary naming the billing entity, prescribed product, pharmacy, initial amount, included services, renewal schedule and cancellation procedure. That is a practical way to resolve this offer’s specific gaps without mistaking incomplete public documentation for proof that a service or protection is absent.

Sources: [9] [8] [12]

Questions & answers

Does IVY RX cost $77 per month for either medication?

The evidence does not establish that. IVY RX advertises GLP-1 medication from $77 with four doses per month and identifies compounded semaglutide and tirzepatide. It does not tie that starting amount to both molecules, every presentation or a particular prepaid option. Request a product-specific checkout total and recurring charge before treating $77 as your monthly budget.

Sources: [7] [9]

Is the $69 microdose offer a separate documented option?

Yes. IVY RX advertises microdose GLP-1 from $69 with four doses per month and describes compounded preparations containing tirzepatide or semaglutide. However, the supplied material does not establish the full cost or which specific product qualifies at that amount. The microdose label also does not establish that an individual is eligible or predict treatment results.

Sources: [5] [3] [4]

Must I pay for three months upfront?

The terms describe a choice of one month prepaid or three months prepaid, both with month-to-month automatic renewal. They do not show which option corresponds to either starting price. Ask for the actual initial charge and the next renewal date; do not assume three-month prepayment is mandatory or that the longer option includes a documented discount.

Sources: [9]

Can I cancel through the IVY RX portal?

The billing clause says plans can be canceled or modified through the patient portal, while another section directs customers to support. Terms require cancellation before the current subscription period ends to avoid the next monthly charge. The marketing page says there are no cancellation fees, but cancellation itself does not establish a refund entitlement for payments already made.

Sources: [9] [6]

How do I request a refund from IVY RX?

The terms say to email info@ivyrx.com with “Refund Request” as the subject within 15 days of the order. They allow a request, not guaranteed approval, and exclude requests after that period. The separate policy rejects physical returns. How these provisions apply to prescribed or shipped medication remains unclear, so ask promptly and keep the written response.

Sources: [9] [12]

Does free delivery mean the medication will arrive in two days?

No universal two-day guarantee is documented. The GLP-1 page advertises arrival in as little as two days, while the help center describes three to five business days in most cases. Shipping is advertised at no additional cost. Confirm the expected timeline for your order, and distinguish that delivery estimate from the separately advertised same-day clinical review.

Sources: [7] [11]

Our assessment

IVY RX documents several potentially useful features for a self-pay comparison: compounded semaglutide and tirzepatide offerings, online evaluation, advertised free consultation and delivery, and portal access to care providers. It also publishes starting prices rather than withholding all cost information. The weakness is the missing connection between those prices and the actual subscription transaction. Prepaid options, discretionary fee increases, unclear eligibility labels and separate cancellation and refund provisions make a written quote important. A reasonable next step is to obtain the exact first charge, renewal amount, product, pharmacy and cancellation confirmation process before authorizing payment. The public evidence supports considering IVY RX as a documented telemedicine option, but not assuming its headline price is a complete or permanently fixed cost.

Visit IVY RX’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

IVY RX Review: What the $77 GLP-1 Starting Price Does—and Does Not—Tell You

At a glance

01Start with the charge, not the headline

02Prepayment and renewal change the budget

03What the advertised price appears to include

04What happens between enrollment and a prescription

05Pharmacy claims and delivery expectations

06Cancellation stops future charges; refunds are separate

07Keep supplements and other catalog products out of the comparison

08Get an accountable answer before authorizing payment